Clinical pharmacokinetics and pharmacodynamics of the oral direct thrombin inhibitor dabigatran etexilate

J Stangier - Clinical pharmacokinetics, 2008 - Springer
The direct thrombin inhibitor dabigatran etexilate is currently in phase III of development for
the prophylaxis and treatment of thromboembolic disorders, with three trials completed in …
被引用次数：912 相关文章

Clinical Pharmacokinetics and Pharmacodynamics of the Oral Direct Thrombin Inhibitor Dabigatran Etexilate

J Stangier - Clinical Pharmacokinetics, 2008 - search.proquest.com
The direct thrombin inhibitor dabigatran etexilate is currently in phase III of development for
the prophylaxis and treatment of thromboembolic disorders, with three trials completed in …

[引用][C] Clinical Pharmacokinetics and Pharmacodynamics of the Oral Direct Thrombin Inhibitor Dabigatran Etexilate

J STANGIER - Clinical pharmacokinetics, 2008 - pascal-francis.inist.fr
Clinical Pharmacokinetics and Pharmacodynamics of the Oral Direct Thrombin Inhibitor
Dabigatran Etexilate CNRS Inist Pascal-Francis CNRS Pascal and Francis Bibliographic …

Clinical pharmacokinetics and pharmacodynamics of the oral direct thrombin inhibitor dabigatran etexilate

J Stangier - Clinical Pharmacokinetics, 2008 - go.gale.com
The direct thrombin inhibitor dabigatran etexilate is currently in phase III of development for
the prophylaxis and treatment of thromboembolic disorders, with three trials completed in …

Clinical Pharmacokinetics and Pharmacodynamics of the Oral Direct Thrombin Inhibitor Dabigatran Etexilate.

J Stangier - Clinical Pharmacokinetics, 2008 - search.ebscohost.com
The direct thrombin inhibitor dabigatran etexilate is currently in phase III of development for
the prophylaxis and treatment of thromboembolic disorders, with three trials completed in …

[引用][C] Clinical pharmacokinetics and pharmacodynamics of the oral direct thrombin inhibitor dabigatran etexilate

J STANGIER - Clin Pharmacokinet, 2008 - cir.nii.ac.jp
Clinical pharmacokinetics and pharmacodynamics of the oral direct thrombin inhibitor
dabigatran etexilate | CiNii Research CiNii 国立情報学研究所 学術情報ナビゲータ[サイニィ] …

Clinical pharmacokinetics and pharmacodynamics of the oral direct thrombin inhibitor dabigatran etexilate

J Stangier - Clinical pharmacokinetics, 2008 - pubmed.ncbi.nlm.nih.gov
The direct thrombin inhibitor dabigatran etexilate is currently in phase III of development for
the prophylaxis and treatment of thromboembolic disorders, with three trials completed in …

Clinical pharmacokinetics and pharmacodynamics of the oral direct thrombin inhibitor dabigatran etexilate.

J Stangier - Clinical Pharmacokinetics, 2008 - europepmc.org
The direct thrombin inhibitor dabigatran etexilate is currently in phase III of development for
the prophylaxis and treatment of thromboembolic disorders, with three trials completed in …

[引用][C] Clnical pharmacokinetics and pharmacodynamics of the oral direct thrombin inhibitor dabigatran etexilate

J STANGIER - Clin Pharmacokinet, 2008 - cir.nii.ac.jp